Back to search
FDAFDA · Food and drugs·Recall number D-0958-2017

BRILINTA (ticagrelor) tablets, 90 mg, 8-count Professional Sample bottles, Rx only, Mfd. for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850; By: AstraZeneca AB, SE-151 85 Sodertalje, Sweden, NDC 0186-0777-08.

Published July 19, 2017 · Recall initiated: May 25, 2017

Summary

FDA records drug Class I recall D-0958-2017, published July 19, 2017 and initiated May 25, 2017. Recalling firm: AstraZeneca Pharmaceuticals, LP; Status: Terminated; Reported quantity: 40,368 bottles; Lot: Lot # JB5047, Exp 10/19. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foriegn Tablets/Capsules: customer complaint that an 8-count professional sample bottle labeled as BRILINTA 90 mg tablets contained 5 ZURAMPIC 200 mg tablets, in addition to the expected 8 BRILINTA tablets.

What to do

Voluntary: Firm initiated · Press Release

Get an email if BRILINTA has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
BRILINTA
Manufacturer
AstraZeneca Pharmaceuticals, LP
Distributor
Nationwide in the USA and Puerto Rico to physician offices.
Lot
Lot # JB5047, Exp 10/19
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was BRILINTA (ticagrelor) tablets, 90 mg, 8-count Professional Sample bottles, Rx only, Mfd. for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850; By: AstraZeneca AB, SE-151 85 Sodertalje, Sweden, NDC 0186-0777-08. recalled?

Yes. FDA published recall D-0958-2017 on July 19, 2017. Reported hazard: Presence of Foriegn Tablets/Capsules: customer complaint that an 8-count professional sample bottle labeled as BRILINTA 90 mg tablets contained 5 ZURAMPIC 200 mg tablets, in addition to the expected 8 BRILINTA tablets.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: BRILINTA.